Variables moduladoras de la calidad de vida de los pacientes oncológicos que reciben nutrición enteral domiciliaria Variables modulating quality of life in cancer patients receivin...

by A Bonada, A Sirgo, R Figueredo, N Guillén, E Mur, J Gumá, J Salas-Salvadó
Published 2004-05-01

A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISE

by H. Payne, A. Robinson, B. Rappe, S. Hilman, U. De Giorgi, S. Joniau, R. Bordonaro, S. Mallick, L. Dourthe, M. Mira Flores, J. Gumà, B. Baron, A. Duran, A. Pranzo, A. Serikoff, M. De Santis
Published 2020-07-01

Pain outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving enzalutamide (ENZA) in a real-world setting: PREMISE

by D. Mott, M. Herdman, A. Robinson, B. Rappe, S. Hilman, U. De Giorgi, S. Joniau, R. Bordonaro, S. Mallick, L-M. Dourthe, M. Mira Flores, J. Gumà, H. Payne, M. De Santis, B. Baron, A. Duran, A. Pranzo, A. Serikoff, M. Pavesi
Published 2020-07-01